# Philip NMI Raskin – FDA Inspection, Jun 23, 2010

Source: https://www.keypedia.com/records/fda_inspections/philip-nmi-raskin/3fa0553a-04f0-48e6-8af1-6f13a0b29dc9
Source feed: FDA_Inspections

> FDA inspection 671386 of Philip NMI Raskin, June 23, 2010. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 671386
- Company Name: Philip NMI Raskin
- Inspection Date: 2010-06-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1226830 - 2024-01-11](https://www.keypedia.com/records/fda_inspections/philip-nmi-raskin/5cbf0401-1e36-4b28-bc06-065b131fcd3e)
- FDA Inspection 1130798 - 2020-09-04
- [FDA Inspection 1041550 - 2018-02-20](https://www.keypedia.com/records/fda_inspections/philip-nmi-raskin/779f9eca-7e9d-4191-b479-a8f527415e82)

Company: https://www.keypedia.com/companies/philip-nmi-raskin/9074ba12-52ed-4918-8a4e-7fbcab7f7974

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
